Childhood Cancer

You are here

Home » Grants » All grants tagged with "Rhabdomyosarcoma"

All grants tagged with "Rhabdomyosarcoma"

Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas
Heide Ford, Ph.D.
University of Colorado Denver
Innovation Grants, Awarded 2014
Determining the Role of Tumor-associated Macrophages in oHSV Antitumor Efficacy
Nicholas Denton
Research Institute at Nationwide Children's Hospital
POST Program Grants, Awarded 2014
The Role of the Receptor Tyrosine Kinase FGFR4 in Human Alveolar Rhabdomyosarcoma Tumorigenesis.
Julie Kephart
Duke University
POST Program Grants, Awarded 2011
Creation and Validation of Novel Cell Line Models for Alveolar Rhabdomyosarcoma
Kaoru Takasaki
Yale School of Medicine
POST Program Grants, Awarded 2013
FANCD2 as a Targetable Biomarker of Radiation Resistance in Pediatric Rhabdomyosarcoma
Nikhil Sebastian
The Ohio State University
POST Program Grants, Awarded 2013
Analysis of the Deviations in the Diagnosis and Treatment Trajectories of Children with Cancer in Low-income Countries and Their Impact on Outcomes: A Comparative Study Between US and Guatemala
Lenka Ilcisin
Dana-Farber Cancer Institute
POST Program Grants, Awarded 2013
Moving EphB4 Therapeutics to Pediatric Phase I/II Trials
Charles Keller, MD
Oregon Health & Science University
Reach Grants, Awarded 2013
Accelerating Access to Cellular Therapies for the Treatment of Childhood Malignancies
Julie Park, MD
Seattle Children’s Hospital and Regional Medical Center
Phase I/II Infrastructure Grants, Awarded 2013
Novel Targeted Therapies for Rhabdomyosarcoma
Michael Dyer, PhD
St. Jude Children’s Research Hospital
Innovation Grants, Awarded 2013
Therapeutic Potential of the MST1/Hippo Tumor Suppressor Pathway in Alveolar Rhabdomyosarcoma
Corinne Mary Linardic, MD, PhD
Duke University
Innovation Grants, Awarded 2013

Pages

All childhood cancer types

Featured Hero

Ailani Myers

Ailani's family calls her a true Warrior Princess as she fights acute lymphoblastic leukemia. Doctors discovered Ailani harbored a rare genetic mutation which makes standard treatment ineffective. Today, Ailani has reached remission!
Read more »